The Attorney General of Louisiana has filed suit against Pfizer, Inc. for concealing “serious issues” regarding Zoloft’s efficacy. Citing a “deliberate, systematic practice” of suppressing unfavorable trial results, publishing ghostwritten articles, and paying key opinion leaders, the lawsuit asserts that Louisiana’s medicaid program reimbursed of prescriptions for the drug that were made under false pretenses.
From the article:
“Pfizer engaged and continues to engage in a deliberate, systematic practice of suppressing unfavorable results for its drug and misleading the state, healthcare providers, consumers and policy makers about the actual efficacy of its drug,” according to the lawsuit. “The defendant caused thousands of false and deceptive claims tobe made to the state by manipulating published efficacy data, paying key opinion leaders to bolster Zoloft’s efficacy and deceptively concealing Zoloft’s inefficacy”